Stock-Based Compensation - Schedule of Stock Options Activity (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Shares
Outstanding at beginning of period (in shares)	914,583	2,089,493	2,647,578
Granted (in shares)	66,540	93,410	146,295
Exercised (in shares)	(401,017)	(1,241,512)	(655,644)
Canceled/Forfeited (in shares)	(30,434)	(26,808)	(48,736)
Outstanding at end of period (in shares)	549,672	914,583	2,089,493
Exercisable at end of period (in shares)	407,617	747,808	1,878,789
Weighted Avg. Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 18.72	$ 14.67	$ 13.75
Granted (in dollars per share)	35.47	31.05	22.25
Exercised (in dollars per share)	13.95	12.62	11.66
Canceled/Forfeited (in dollars per share)	26.62	28.49	27.77
Outstanding at end of period (in dollars per share)	23.80	18.72	14.67
Exercisable at end of period (in dollars per share)	$ 21.14	$ 16.71	$ 13.35
Intrinsic value of options exercised	$ 11.5	$ 29.3	$ 11.0
Weighted average remaining contractual life of options outstanding (in years)	5 years 6 months	4 years 9 months 18 days	4 years 1 month 6 days
Aggregate intrinsic value of options outstanding	$ 12.4
Weighted average remaining contractual life of options exercisable (in years)	4 years 6 months	3 years 10 months 24 days	3 years 4 months 24 days
Aggregate intrinsic value of options exercisable	$ 10.3

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.